OptimizeRx (OPRX) Short-term Investments (2022 - 2023)
OptimizeRx (OPRX) posted Short-term Investments of $53.6 million for Q3 2023, up 1.3% sequentially from $52.9 million in Q2 2023, and up 43.11% YoY from $37.5 million in Q3 2022.
OptimizeRx (OPRX) Short-term Investments (2022 - 2023) Analysis & Trends
OptimizeRx has reported Short-term Investments for 2 years, with the latest figure at $53.6 million in Q3 2023.
- Quarterly Short-term Investments rose 43.11% year-over-year to $53.6 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $53.6 million (up 43.11% YoY) and the FY2022 annual result came in at $55.9 million, changed N/A from the prior year.
- Short-term Investments advanced to $53.6 million in Q3 2023 per OPRX's latest filing, from $52.9 million in the prior quarter.
- Over five years, Short-term Investments peaked at $57.3 million in Q1 2023 and troughed at $37.5 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn |
| 10 | OptimizeRx | 164.25 Mn | 140.15 Mn | 15.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 53.62 Mn |
| Jun 30, 2023 | 52.93 Mn |
| Mar 31, 2023 | 57.26 Mn |
| Dec 31, 2022 | 55.93 Mn |
| Sep 30, 2022 | 37.47 Mn |